Pharmaceutical/Biotech

Biden’s Vaccine Mandate Risks Overwhelming U.S. Testing Capacity

September 16, 2021

The U.S. may not have enough tests to keep pace with the Biden administration’s tightened workplace COVID-19 mitigation measures.

VIDEO

Watch: Are We Facing Another Shortage of PPE?

September 3, 2021

Robert J. Bowman, SupplyChainBrain

Michael Einhorn, chief executive officer of medical supplier Dealmed, explains how the healthcare purchasing system frustrates attempts to diversify sourcing of personal protective equipment and head off future shortages in times of emergency.

Get Shots or Get Out, U.S. Employers Are Telling Workers

August 27, 2021

Bloomberg

Vaccine mandates are beginning a march across the U.S., constricting the places that people who have shunned the shots can work, shop and play.

Worker Support Grows for Harsher Vaccine Stances From Employers

August 25, 2021

Bloomberg

As U.S. regulatory approval of Pfizer Inc.’s COVID-19 shot paves the way for companies to get more aggressive with inoculations, American workers are increasingly supportive of punitive measures for unvaccinated colleagues.

U.S. Booster Push Is Fresh Challenge for Healthcare Providers

August 25, 2021

Bloomberg

As the Biden administration moved last week to make COVID-19 booster shots available for many U.S. adults, health-care providers are preparing for a fresh pandemic battle: getting uncertain or confused patients to take another dose.

Counterfeit Goods Are Everywhere. This Technology Sweeps Them From Supply Chains.

August 24, 2021

Benjamin Kiunisala, SCB Contributor

The counterfeit drug market alone costs more than $200 billion per year — enough to bring 13 new drugs to market.

Wednesday, Sep 15, 2021

How to Partner with Impact-Led Social Enterprises in Your Supply Chain

August 19, 2021

Avetta

Companies across industries are looking for ways to make their supply chains more sustainable, resilient, and socially responsible. Social enterprises can be valuable partners in achieving these goals.

The Winners and Losers in the Bipartisan Infrastructure Bill

August 3, 2021

Bloomberg

A Senate plan to spend $550 billion on U.S. infrastructure stands to benefit industries heavily dependent on transportation, with companies including Amazon.com Inc., FedEx Corp. and Comcast Corp. among the biggest winners.

Covid Vaccine Makers Take Aim at Bottlenecks to Speed Production

July 20, 2021

Bloomberg

A new initiative aims to overcome bottlenecks that have hampered the production and global rollout of COVID-19 shots, linking manufacturers with suppliers of vital materials.

How Fujifilm’s Pivot to Health Care, Chips Paid Off in the Pandemic

July 15, 2021

Bloomberg

Fujifilm Holdings Corp.’s tough decision to accept the demise of its film and digital photography businesses and embrace the health care and semiconductor sectors was validated last year.

Pharmaceutical/Biotech

The latest supply-chain news, analysis, trends and tools for executives in the pharmaceutical and biotech industries. Learn how pharmaceutical and biotech companies and their suppliers around the world are managing the flow of products across all channels of the enterprise. Experts sound off on forecasting and demand planning, supply-chain visibility, logistics outsourcing, inventory optimization, transportation management, warehouse management, supply-chain security, corporate social responsibility and more.